Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter Hoefsloot

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|November 28, 2023
Successful addition of topical antibiotic treatment after surgery in treatment-refractory nontuberculous mycobacterial skin and soft tissue infectionsRalf Stemkens, Maarten Cobussen, Erik de Laat, et al.
Diagnostic Microbiology and Infectious Disease|July 21, 2018
Mycobacterium avium complex bacteria remain viable in sputum during storage and refrigerationLian J Pennings, Sanne Zweijpfenning, Mike M Ruth, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 12, 2018
Dissemination of localized Mycobacterium malmoense infection in an immunocompromised patientSanne M H Zweijpfenning, Lydia Schipper, Vincent A M Duurkens, et al.
The European Respiratory Journal|December 10, 2015
Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activityMichiel H C Slaats, Wouter Hoefsloot, Cecile Magis-Escurra, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|July 4, 2025
Medication adherence in patients with nontuberculous mycobacterial diseaseArthur Lemson, Fleur Dijkhuizen, Ralf Stemkens, et al.
The European Respiratory Journal|April 20, 2019
Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary diseaseAnne Huiberts, Sanne M H Zweijpfenning, Lian J Pennings, et al.
Access Microbiology|October 16, 2020
The tough process of unmasking the slow-growing mycobacterium: case report of <i>Mycobacterium microti</i> infectionCornelia A M van de Weg, Jurriaan E M de Steenwinkel, Jelle R Miedema, et al.
Chest|December 1, 2023
Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized TrialSanne M H Zweijpfenning, Rob Aarnoutse, Martin J Boeree, et al.
The Journal of Infection|January 10, 2013
Prevalence of nontuberculous mycobacteria in COPD patients with exacerbationsWouter Hoefsloot, Jakko van Ingen, Cecile Magis-Escurra, et al.
ERJ Open Research|November 25, 2021
Treatment of severe <i>Mycobacterium avium</i> complex pulmonary disease with adjunctive amikacin and clofazimine <i>versus</i> standard regimen alone: a retrospective studySanne M H Zweijpfenning, Stephan E P Kops, Martin J Boeree, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|November 28, 2023
Successful addition of topical antibiotic treatment after surgery in treatment-refractory nontuberculous mycobacterial skin and soft tissue infectionsRalf Stemkens, Maarten Cobussen, Erik de Laat, et al.
Diagnostic Microbiology and Infectious Disease|July 21, 2018
Mycobacterium avium complex bacteria remain viable in sputum during storage and refrigerationLian J Pennings, Sanne Zweijpfenning, Mike M Ruth, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 12, 2018
Dissemination of localized Mycobacterium malmoense infection in an immunocompromised patientSanne M H Zweijpfenning, Lydia Schipper, Vincent A M Duurkens, et al.
The European Respiratory Journal|December 10, 2015
Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activityMichiel H C Slaats, Wouter Hoefsloot, Cecile Magis-Escurra, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|July 4, 2025
Medication adherence in patients with nontuberculous mycobacterial diseaseArthur Lemson, Fleur Dijkhuizen, Ralf Stemkens, et al.
The European Respiratory Journal|April 20, 2019
Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary diseaseAnne Huiberts, Sanne M H Zweijpfenning, Lian J Pennings, et al.
Access Microbiology|October 16, 2020
The tough process of unmasking the slow-growing mycobacterium: case report of <i>Mycobacterium microti</i> infectionCornelia A M van de Weg, Jurriaan E M de Steenwinkel, Jelle R Miedema, et al.
Chest|December 1, 2023
Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized TrialSanne M H Zweijpfenning, Rob Aarnoutse, Martin J Boeree, et al.
The Journal of Infection|January 10, 2013
Prevalence of nontuberculous mycobacteria in COPD patients with exacerbationsWouter Hoefsloot, Jakko van Ingen, Cecile Magis-Escurra, et al.
ERJ Open Research|November 25, 2021
Treatment of severe <i>Mycobacterium avium</i> complex pulmonary disease with adjunctive amikacin and clofazimine <i>versus</i> standard regimen alone: a retrospective studySanne M H Zweijpfenning, Stephan E P Kops, Martin J Boeree, et al.
Pageof 8